132 related articles for article (PubMed ID: 37855745)
21. Impact of Local Control on Clinical Course in Stage IVC Anaplastic Thyroid Carcinoma.
Yamazaki H; Sugino K; Katoh R; Masudo K; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Ito K
World J Surg; 2022 Dec; 46(12):3034-3042. PubMed ID: 36127501
[TBL] [Abstract][Full Text] [Related]
22. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
23. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer.
Zhang L; Luo H; Wang L; Liu Y; Rui S; Wu Z; Wei T; Gong R; Li Z; Zhu J
J Surg Oncol; 2020 Oct; 122(5):897-905. PubMed ID: 32596828
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
Yamazaki H; Sugino K; Matsuzu K; Masaki C; Akaishi J; Hames K; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Masuda M; Ito K
Endocrine; 2020 Oct; 70(1):115-122. PubMed ID: 32307657
[TBL] [Abstract][Full Text] [Related]
26. Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study.
Chintakuntlawar AV; Rumilla KM; Smith CY; Jenkins SM; Foote RL; Kasperbauer JL; Morris JC; Ryder M; Alsidawi S; Hilger C; Bible KC
J Clin Endocrinol Metab; 2017 Jun; 102(6):1943-1950. PubMed ID: 28324060
[TBL] [Abstract][Full Text] [Related]
27. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Xu B; Fuchs T; Dogan S; Landa I; Katabi N; Fagin JA; Tuttle RM; Sherman E; Gill AJ; Ghossein R
Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
[No Abstract] [Full Text] [Related]
28. Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years.
Jacob J; Vordermark D; Lorenz K; Medenwald D
Radiat Oncol; 2023 Apr; 18(1):71. PubMed ID: 37076888
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer.
Zhang H; Zhao YC; Wu Q; Wang L; Sun S
Clin Endocrinol (Oxf); 2021 Sep; 95(3):498-507. PubMed ID: 33864292
[TBL] [Abstract][Full Text] [Related]
30. Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients.
Kong N; Xu Q; Zhang Z; Cui A; Tan S; Bai N
Front Endocrinol (Lausanne); 2021; 12():704596. PubMed ID: 34385977
[TBL] [Abstract][Full Text] [Related]
31. Marginal treatment benefit in anaplastic thyroid cancer.
Haymart MR; Banerjee M; Yin H; Worden F; Griggs JJ
Cancer; 2013 Sep; 119(17):3133-9. PubMed ID: 23839797
[TBL] [Abstract][Full Text] [Related]
32. A relook at the 8th edition of the AJCC TNM staging system of anaplastic thyroid carcinoma: A SEER-based study.
Xiang J; Wang Z; Sun W; Zhang H
Clin Endocrinol (Oxf); 2021 Apr; 94(4):700-710. PubMed ID: 33368530
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
Wei YC; Zhang D; Chai Y; Dong M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
[No Abstract] [Full Text] [Related]
34. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer.
Chen YH; Cabanillas M; Sperling J; Xu L; Goswami M; Maniakas A; Williams MD; Lai SY; Busaidy N; Dadu R; Zafereo ME; Wang JR
Thyroid; 2023 Mar; 33(3):321-329. PubMed ID: 36511380
[No Abstract] [Full Text] [Related]
35. Low Lymphocyte-to-Monocyte Ratios Are Associated with Poor Overall Survival in Anaplastic Thyroid Carcinoma Patients.
Ahn J; Song E; Oh HS; Song DE; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Thyroid; 2019 Jun; 29(6):824-829. PubMed ID: 30864902
[No Abstract] [Full Text] [Related]
36. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
37. Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.
Zhang K; Wang X; Wei T; Li Z; Zhu J; Chen YW
Front Endocrinol (Lausanne); 2024; 15():1347362. PubMed ID: 38544687
[TBL] [Abstract][Full Text] [Related]
38. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.
Iyer PC; Dadu R; Gule-Monroe M; Busaidy NL; Ferrarotto R; Habra MA; Zafereo M; Williams MD; Gunn GB; Grosu H; Skinner HD; Sturgis EM; Gross N; Cabanillas ME
J Immunother Cancer; 2018 Jul; 6(1):68. PubMed ID: 29996921
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for Korean patients with anaplastic thyroid carcinoma.
Kim TY; Kim KW; Jung TS; Kim JM; Kim SW; Chung KW; Kim EY; Gong G; Oh YL; Cho SY; Yi KH; Kim WB; Park DJ; Chung JH; Cho BY; Shong YK
Head Neck; 2007 Aug; 29(8):765-72. PubMed ID: 17274052
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
